Axsome Therapeutics, Inc. AXSM

Set alert

Price alert · AXSM

All alert types
142.00 USD +5.99 +4.40%

As of Nov 3, 10:13 AM ET

Bid
141.89 × 1
Ask
142.10 × 1
136.88 Day range 145.50
134.93 52-week range 255.17
YTD
-22.25%
1 year
+4.60%
Open
136.88
Prev close
136.01
Mkt cap
7.47B
Vol
299.77K
Avg vol
810.47K
EPS
-3.03
P/E
0.00
Div yield
0.00%
More statistics
Low
136.88
High
145.50
Forward P/E
32.37
Beta
0.83
Short ratio
3.67
Inst. own
74.49%
Dividend
0.00
Ex-div date
Earnings
Feb 22, 2027
50-d avg
184.76
200-d avg
199.33
1y target
277.86

5D chart

Chart tools
Interval

Events in this range
  • Nov 2, 2026Earnings: -0.25; estimate -0.63425; surprise 60.58%
Signals (82)
NameTimeAgo
RSI: OverboughtNov 3, 9:30 AM43 minutes ago
RSI: OverboughtNov 2, 3:40 PM18 hours ago
RSI: OverboughtNov 2, 3:05 PM19 hours ago
SMA: BullishNov 2, 2:30 PM19 hours ago
MACD: Buy SignalNov 2, 2:30 PM19 hours ago
SMA: BullishNov 2, 2:05 PM20 hours ago
SMA: BearishNov 2, 1:30 PM20 hours ago
SMA: BearishNov 2, 1:30 PM20 hours ago
MACD: Sell SignalNov 2, 1:30 PM20 hours ago
SMA: BullishNov 2, 1:15 PM20 hours ago
MACD: Buy SignalNov 2, 1:15 PM20 hours ago
MACD: Sell SignalNov 2, 1:10 PM21 hours ago
SMA: BearishNov 2, 12:50 PM21 hours ago
SMA: BullishNov 2, 11:45 AM22 hours ago
SMA: BullishNov 2, 11:15 AM22 hours ago
MACD: Buy SignalNov 2, 11:05 AM23 hours ago
MACD: Sell SignalNov 2, 10:55 AM23 hours ago
MACD: Buy SignalNov 2, 10:50 AM23 hours ago
SMA: BearishNov 2, 9:30 AM1 day ago
SMA: BearishNov 2, 9:30 AM1 day ago

Newest 20 of 82.

Revenue & Expenses

Revenue by
Income Tax Benefit → Expenses: $530.00KUnited States → Revenue: $628.62MExpenses → Selling, General & Admin: $570.60MExpenses → Research & Development: $183.28MExpenses → Other Operating Expenses: $6.38MExpenses → Interest Expense: $6.56MExpenses → Other Expenses: $7.91MGross Profit → Expenses: $591.02MRevenue → Gross Profit: $591.02MRevenue → Cost of Revenue: $47.48MNon-US → Revenue: $5.18MNet Loss → Expenses: $183.17MIncome Tax Benefit$530.00KGross Profit$591.02MNet Loss$183.17MCost of Revenue$47.48MExpenses$774.72MSelling, General & Admin$570.60MResearch & Development$183.28MOther Operating Expenses$6.38MInterest Expense$6.56MOther Expenses$7.91MRevenue$638.50MUnited States$628.62MNon-US$5.18M

Latest period ending Dec 31, 2025 · select a line to chart its full history

AXSM annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
638.50M385.69M270.60M50.04M0
591.02M352.39M244.53M44.84M0
-166.76M-280.56M-231.82M-179.80M-124.71M
-183.17M-287.22M-239.24M-187.13M-130.40M
-3.68-5.99-5.27-4.60-3.47
AXSM annual balance sheet
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
322.93M315.35M386.19M200.84M86.47M
689.80M568.50M588.24M331.48M87.79M
601.51M511.48M397.26M221.92M72.15M
215.57M191.53M186.37M94.68M49.71M
88.30M57.02M190.98M109.56M15.63M
AXSM annual cash flow
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
-93.41M-128.41M-145.08M-116.51M-108.23M
-480.00K-270.00K-582.00K-53.70M-308.00K
101.47M57.84M331.01M284.58M11.13M
-480.00K-270.00K-582.00K-702.00K-308.00K
7.58M-70.84M185.35M114.37M-97.40M